-
Sector Analysis
United States (US) Defense Market Size, Trends, Budget Allocation, Regulations, Acquisitions, Competitive Landscape and Forecast to 2028
US Defense Market Report Overview The US defense budget was worth $818.8 billion in 2023, which was a 10.7% rise from the previous year. This is in response to the deteriorating global security environment such as the Russian invasion of Ukraine and continued tensions with China over territory in the South China Sea and wider Indo-Pacific. Numerous geo-strategic and domestic political imperatives continue to drive US expenditure as defense capabilities gain growing political importance. The country’s defense budget is expected to...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BMX-001 in Rectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BMX-001 in Rectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BMX-001 in Rectal Cancer Drug Details: BMX-001 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BMX-001 in Hypopharyngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BMX-001 in Hypopharyngeal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BMX-001 in Hypopharyngeal Cancer Drug Details: BMX-001 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BMX-001 in Laryngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BMX-001 in Laryngeal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BMX-001 in Laryngeal Cancer Drug Details: BMX-001 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BMX-001 in Oropharyngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BMX-001 in Oropharyngeal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BMX-001 in Oropharyngeal Cancer Drug Details: BMX-001 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BMX-001 in Oral Cavity (Mouth) Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BMX-001 in Oral Cavity (Mouth) Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BMX-001 in Oral Cavity (Mouth) Cancer Drug Details: BMX-001 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BMX-001 in Head And Neck Squamous Cell Carcinoma (HNSC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BMX-001 in Head And Neck Squamous Cell Carcinoma (HNSC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BMX-001 in Head And Neck Squamous Cell...
-
Bry Det 20 Mine
The Bry Det 20 Mine is a coal mine in United States. It is currently in operation. Empower your strategies with our Bry Det 20 Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons...
-
Product Insights
Mozura
Mozura is an Onshore Wind project located in Ulcinj, Montenegro. The project is owned by Enemalta Plc; Malta Montenegro Wind Power JV Ltd and was developed by Audax Renovables SA ; Celebic Company; Enemalta Plc. The project came online in 2019. Empower your strategies with our Mozura report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase,...
-
Product Insights
SGZ & SGA Sugars Cogeneration Power Plant
SGZ & SGA Sugars Cogeneration Power Plant is a biopower project located in Maharashtra, India. The project is owned and being developed by SGZ & SGA Sugars (JV) Ltd. The project is at the permitting stage. Empower your strategies with our SGZ & SGA Sugars Cogeneration Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the...